Overview |
bs-21401R-PE-Cy5.5 |
VLDL Receptor Polyclonal Antibody, PE-Cy5.5 Conjugated |
WB |
Human, Mouse, Rat, Dog, Pig, Rabbit, Horse |
Specifications |
PE-Cy5.5 |
Rabbit |
KLH conjugated synthetic peptide derived from human VLDL Receptor |
Polyclonal |
IgG |
1ug/ul |
Purified by Protein A. |
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
Target |
7436 |
P98155 |
Cytomembrane |
Very low density lipoprotein receptor; VLDL R; VLDLR; VLDL-R; VLDLRCH. |
Binds VLDL and transports it into cells by endocytosis. In order to be internalized, the receptor-ligand complexes must first cluster into clathrin-coated pits. Binding to Reelin induces tyrosine phosphorylation of Dab1 and modulation of Tau phosphorylation (By similarity). |
Application Dilution |
WB |
1:300-5000 |